Juniper Pharmaceuticals Inc logo

JNP - Juniper Pharmaceuticals Inc News Story

$11.5 0.0  0.0%

Last Trade - 13/08/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £39.4m
Position in Universe th / 6853

BRIEF-Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform To Daré Bioscience

Wed 25th April, 2018 1:09pm
April 25 (Reuters) - Juniper Pharmaceuticals Inc  JNP.O :
    * JUNIPER PHARMACEUTICALS LICENSES INTRAVAGINAL RING (IVR)
PLATFORM TO DARÉ BIOSCIENCE
    * JUNIPER PHARMACEUTICALS - ELIGIBLE TO RECEIVE UP TO $43.75
MILLION IN MILESTONES FOR EACH IVR CANDIDATE, PLUS ROYALTIES ON
FUTURE SALES
    * JUNIPER PHARMACEUTICALS - UNDER AGREEMENT, DARÉ TO BE
RESPONSIBLE FOR CONDUCTING ALL RESEARCH, DEVELOPMENT, AND
COMMERCIAL ACTIVITIES FOR PROGRAM

Source text for Eikon:  ID:nPn3qmMpha 
Further company coverage:  JNP.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.